Evidence map›Paper›PMID 38385642›Full record

ArticleeLife2024

Tailoring T

Anil Verma, Chase E Hawes, Sonny R Elizaldi, Justin C Smith, Dhivyaa Rajasundaram, Gabriel Kristian Pedersen, Xiaoying Shen, LaTonya D Williams, Georgia D Tomaras, Pamela A Kozlowski and 2 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Anil Verma *Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, United States.
Chase E Hawes *Graduate Group in Immunology, University of California, Davis, Davis, United States.
Sonny R ElizaldiGraduate Group in Immunology, University of California, Davis, Davis, United States.
Justin C SmithDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, United States.ORCID https://orcid.org/0000-0001-7702-7920
Dhivyaa RajasundaramBioinformatics Core, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, United States.
Gabriel Kristian PedersenStatens Serum Institute, Copenhagen, Denmark.
Xiaoying ShenCenter for Human Systems Immunology, Durham, United States.
LaTonya D WilliamsCenter for Human Systems Immunology, Durham, United States.
Georgia D TomarasCenter for Human Systems Immunology, Durham, United States.
Pamela A KozlowskiDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, United States.
Rama R AmaraDepartment of Microbiology and Immunology, Emory University, Atlanta, United States.
Smita S IyerDepartment of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, United States.ORCID https://orcid.org/0000-0002-8918-7005
Center for Human Genetics · USLouisiana State University Health Sciences Center New Orleans · USUniversity of California, Davis · USUniversity of Pittsburgh · USChildren's Hospital of Pittsburgh · USDuke University · USEmory University · USStatens Serum Institut · DK

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Nonhuman Primate Reagent ResourceU24AI126683 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Diogo Magnani · 2016 to 2026
$20.1M
Resource for Nonhuman Primate Cell Depleting AntibodiesR24OD010976 · OD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ENGELMAN, KATHLEEN, MAGNANI, DIOGO · 2012 to 2019
$4.7M
Targeting CD4 TFH cells to enhance HIV vaccine-induced humoral immunityK01OD023034 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2016 to 2018
$1.0M
Targeting CD4 T follicular helper cells for enhancing HIV vaccine induced humoral immunityR56AI150409 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI IYER, SWAMINATHAN SMITA · 2021 to 2021
$774k
NIAID NIH HHS HHSN272201800004CNIAID NIH HHS P30 AI064518NIAID NIH HHS R56 AI150409NIAID NIH HHS U24 AI126683NIH HHS HHSN272201800004CNIH HHS K01 OD023034NIH HHS P30 AI064518NIH HHS P51 OD011107NIH HHS R24 OD010976NIH HHS R56AI150409
6 · The paper itself

Abstract

CD4 T follicular helper cells (T

Indexed as

AIDS VaccinesHIV-1AnimalsChemokine CXCL10DNAHIV AntibodiesMacaca mulattaAIDS VaccinesChemokine CXCL10DNAHIV Antibodiesantibody persistenceimmunologyinflammationrhesus macaqueT-dependent B cell responsevaccine efficacy

Identifiers

PMID38385642
PMCPMC10942585
OpenAlexW4387362864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.